Quantitative analysis for BillionToOne, Inc. (BLLN) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (68.0) (grade B). 35 signals analyzed (30 differentiated alt-data).
BLLN stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-28 | $82.25 | $75.96 | $78.23 |
| 2026-05-08 | $94.46 | $85.10 | $92.96 |
| 2026-05-20 | $84.99 | $78.01 | $83.38 |
| 2026-06-02 | $95.85 | $88.45 | $94.25 |
| 2026-06-12 | $103.45 | $96.76 | $101.12 |
| 2026-06-25 | $114.80 | $108.01 | $112.24 |
| 2026-07-08 | $121.00 | $113.30 | $120.60 |
| 2026-07-20 | $132.21 | $122.20 | $125.14 |
| 2026-07-30 | $140.00 | $130.86 | $139.59 |
| 2026-08-12 | $98.92 | $96.00 | $97.45 |
| 2026-08-24 | $97.30 | $92.50 | $96.74 |
| 2026-09-03 | $99.61 | $94.16 | $99.50 |
How BillionToOne, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals, Ltd. | $4.1B | — |
| NAMS | NewAmsterdam Pharma Company N.V. | $4.2B | — |
| HNGE | Hinge Health, Inc. | $4.2B | — |
| MANE | Veradermics, Incorporated | $4.4B | — |
View all Health Care stocks by valuation and signals →
BillionToOne, Inc. (BLLN) scores Buy (68.0), and the composite conceals a 71-point disagreement between its dimensions. It is strongest on ML forecast at 79 and technicals at 73, and weakest on analyst consensus at 8. A stock can carry ML forecast that high while analyst consensus sits at 8; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| ML forecast | 79 |
| technicals | 73 |
| competitive moat | 60 |
| analyst consensus | 8 |
StoQuant analyzes 35 signals (30 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on BillionToOne, Inc. (BLLN): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/BLLN"><img src="https://stoquant.com/badge/BLLN.svg" alt="BillionToOne, Inc. (BLLN) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.